CID 15951527

Enzalutamide impurity i

Structural Information

Molecular Formula
C21H17F3N4O2S
SMILES
CC1(C(=O)N(C(=S)N1C2=CC=C(C=C2)C(=O)NC)C3=CC(=C(C=C3)C#N)C(F)(F)F)C
InChI
InChI=1S/C21H17F3N4O2S/c1-20(2)18(30)27(15-9-6-13(11-25)16(10-15)21(22,23)24)19(31)28(20)14-7-4-12(5-8-14)17(29)26-3/h4-10H,1-3H3,(H,26,29)
InChIKey
GOTJOTNPYGBVOP-UHFFFAOYSA-N
Compound name
4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-N-methylbenzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

75
Patents

446.10242 Da
Monoisotopic Mass

3.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 447.10970 204.7
[M+Na]+ 469.09164 216.1
[M-H]- 445.09514 207.3
[M+NH4]+ 464.13624 214.1
[M+K]+ 485.06558 208.3
[M+H-H2O]+ 429.09968 188.0
[M+HCOO]- 491.10062 211.6
[M+CH3COO]- 505.11627 238.7
[M+Na-2H]- 467.07709 200.2
[M]+ 446.10187 198.3
[M]- 446.10297 198.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe